Respiratory Infections News

The FDA on Thursday granted full approval for Paxlovid, making it the first oral antiviral pill approved by the FDA to treat COVID-19 in adults.

WASHINGTON — Those with incomplete COVID-19 vaccination faced elevated risk for nonrespiratory features, such as fever and tachycardia, according to research presented at the American Thoracic Society International Conference.

The FDA has approved IV sulbactam-durlobactam to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.

The FDA gets an A– for moving relatively quickly to get test kits approved and gearing up for vaccine approval, although with less urgency for children.

I actually knew I wanted to study infectious diseases even before embarking on a career in medicine.

An FDA advisory committee on Thursday voted in favor of a respiratory syncytial virus vaccine that would be administered to pregnant people to protect their infants.

Higher dose methylprednisolone and low-dose dexamethasone treatments in patients with COVID-19 pneumonia showed similar 28-day mortality rates, according to study results published in European Respiratory Journal.

The National Institute of Allergy and Infectious Diseases announced this week that it has started enrolling participants in a phase 1 trial testing an experimental universal influenza vaccine that uses a messenger RNA platform.

A study of more than 14,000 febrile infants found that UTIs, bacteremia and bacterial meningitis were less common among those who tested positive for SARS-CoV-2 than those who did not, according to findings published in JAMA Network Open.

Throughout the COVID-19 pandemic, infectious disease experts made contributions to help control the outbreak and improve public understanding of the new disease.